Jurors have concluded that Johnson & Johnson’s Janssen unit willfully violated South Carolina’s unfair trade practices law when it promoted off-label use of the anti-psychotic Risperdal.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *